Invesque continues to sell SNFs in shift to predominantly private-pay properties … Assisted living, healthcare settings account for more than half of US waterborne disease exposures … CMS releases...
Telemedicine increases access to care for assisted living residents with dementia: study
By
Kimberly Bonvissuto
May 30, 2023
Although racial/ethnic and socioeconomically disadvantaged populations were less likely to use telemedicine early in the COVID-19 pandemic, a new study finds that telemedicine offered a way for members...
Dementia awareness, resident protection at center of 2 bills before lawmakers
By
Kimberly Bonvissuto
Feb 27, 2024
Raising dementia awareness is the goal of separate bills under consideration by lawmakers in Ohio and Georgia.
2023 proved to be a ‘landmark’ year in progress toward treatment of Alzheimer’s disease
By
Kimberly Bonvissuto
Dec 15, 2023
The 2023 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday, highlighting “landmark” progress made over the past year in understanding...
Behavioral health-memory care model serves increasing needs in senior living
By
Kimberly Bonvissuto
Aug 16, 2023
Cascade Senior Living Servicesgot creative by pursuing uncommon contracts and specialty partnerships to serve people living with significant mental health or dementia diagnoses.
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Dementia to cost nation $321 billion this year, Alzheimer’s Association says
By
Kimberly Bonvissuto
Mar 16, 2022
This year, Alzheimer’s and other dementias will cost the nation $321 billion, increasing to $1 trillion by 2050, according to a report released Tuesday by the Alzheimer’s Association.
NIH requests additional $321M for Alzheimer’s, dementia research
By
Kimberly Bonvissuto
Aug 02, 2022
The National Institutes of Health has requested an additional $321 million in fiscal year 2024 for research into Alzheimer’s and other dementias.
Alzheimer’s Association asks CMS to provide full coverage of FDA-approved dementia drugs
By
Kimberly Bonvissuto
Dec 21, 2022
Every day, more than 2,000 older adults living with mild dementia may transition to a more advanced stage of the disease and no longer be eligible for lecanemab and other antibodies targeting amyloid under...
Industry advocates join coalition to support federal bill requiring use of Alzheimer’s detection tools
By
Kimberly Bonvissuto
Oct 04, 2023
A bipartisan bill requiring the use of cognitive impairment detection tools in the early detection of Alzheimer’s disease and related dementias has the support of the senior living industry.